Michael E. Berens

Active 1988–2025

90
Papers
18,421
Citations
72
h-index
84
i10-index

Citations

Citations per year for Michael E. Berens1980: 1 citations1981: 1 citations1986: 1 citations1987: 1 citations1989: 2 citations1990: 3 citations1991: 6 citations1992: 10 citations1993: 4 citations1994: 8 citations1995: 13 citations1996: 23 citations1997: 8 citations1998: 10 citations1999: 29 citations2000: 17 citations2001: 39 citations2002: 32 citations2003: 54 citations2004: 67 citations2005: 100 citations2006: 98 citations2007: 165 citations2008: 131 citations2009: 194 citations2010: 151 citations2011: 169 citations2012: 136 citations2013: 133 citations2014: 97 citations2015: 126 citations2016: 114 citations2017: 115 citations2018: 187 citations2019: 605 citations2020: 765 citations2021: 804 citations2022: 726 citations2023: 684 citations2024: 944 citations2025: 500 citations2026: 24 citations1982–1985: no citations, so these years are not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,410 citing papers, 28.2% of this breakdownChina: 1,510 citing papers, 17.7% of this breakdownGermany: 555 citing papers, 6.5% of this breakdownUnited Kingdom: 373 citing papers, 4.4% of this breakdownItaly: 335 citing papers, 3.9% of this breakdownFrance: 280 citing papers, 3.3% of this breakdownCanada: 252 citing papers, 2.9% of this breakdownJapan: 248 citing papers, 2.9% of this breakdownAustralia: 194 citing papers, 2.3% of this breakdownSpain: 185 citing papers, 2.2% of this breakdownSouth Korea: 168 citing papers, 2% of this breakdownIndia: 157 citing papers, 1.8% of this breakdown
0%28.2%Other 21.9%

Fields

  • Medicine47%
  • Biochemistry, Genetics and Molecular Biology35.5%
  • Neuroscience3.7%
  • Computer Science3.3%
  • Mathematics2.6%
  • Engineering2.5%
  • Other5.4%

Topics

  • Ferroptosis and cancer prognosis6.9%
  • Glioma Diagnosis and Treatment6.8%
  • RNA modifications and cancer3.5%
  • Cancer, Lipids, and Metabolism3.3%
  • Cancer Genomics and Diagnostics2.2%
  • Epigenetics and DNA Methylation2.2%
  • Other75.1%

Coauthors

All papers

Open in search
  1. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cindy Hon, Yu Chen, William C. Hahn, Mitchell P. Levesque, John G. Doench, Michael E. Berens, Alykhan F. Shamji, Paul A. Clemons, Brent R. Stockwell, Stuart L. Schreiber - Nature 2017 cited by 2,059

  2. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

    Authors: , , , , , , , , , , , - Nature 2017 cited by 1,804

  3. Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Evan W. Newell, Jeffrey R. Whiteaker, Lei Zhao, Amanda G. Paulovich, Navin Pinto, Juliane Gust, Rebecca Gardner, Michael C. Jensen, Julie R. Park - Cancer Discovery 2022 cited by 263

  4. An anatomic transcriptional atlas of human glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John G. Hohmann, Parvinder Hothi, Robert Howard, Kevin Joines, Ali Kriedberg, Leonard Kuan, Chris Lau, Felix Lee, Hwahyung Lee, Tracy Lemon, Fuhui Long, Naveed Mastan, Erika Mott, Chantal Murthy, Kiet Ngo, Eric N. Olson, Melissa Reding, Zack L. Riley, David Rosen, David Sandman, Nadiya V. Shapovalova, Clifford R. Slaughterbeck, Andrew Sodt, Graham Stockdale, Aaron Szafer, Wayne Wakeman, Paul Wohnoutka, Steven J. White, D. C. B. Marsh, Robert Rostomily, Lydia Ng, Chinh Dang, Allan R. Jones, Bart P. Keogh, Haley Gittleman, Jill S. Barnholtz‐Sloan, Patrick J. Cimino, Megha Uppin, C. Dirk Keene, Farrokh Farrokhi, Justin D. Lathia, Michael E. Berens, Antonio Iavarone, Amy Bernard, Ed S. Lein, John W. Phillips, Steven Rostad, Charles Cobbs, Michael Hawrylycz, Greg Foltz - Science 2018 cited by 706

  5. Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Caterina Giannini, Robert B. Jenkins, Ian F. Parney, Jann N. Sarkaria - Clinical Cancer Research 2019 cited by 239

  6. Sex Differences in Cancer Incidence and Survival: A Pan-Cancer Analysis

    Authors: , , , , , , , , , , - Cancer Epidemiology Biomarkers & Prevention 2020 cited by 199

  7. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 360

  8. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2015 cited by 290

  9. Females have the survival advantage in glioblastoma

    Authors: , , , , - Neuro-Oncology 2018 cited by 202

  10. Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

    Authors: , , , - Journal of Clinical Oncology 2003 cited by 1,206

  11. Targeting adaptive glioblastoma: an overview of proliferation and invasion

    Authors: , , - Neuro-Oncology 2014 cited by 268

  12. Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy

    Authors: , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 cited by 195

  13. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2023 cited by 56

  14. Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2022 cited by 57

  15. Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas

    Authors: , , , , , , , , , , , - Neuro-Oncology 2021 cited by 88

  16. Toward precision medicine in glioblastoma: the promise and the challenges

    Authors: , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 cited by 223

  17. Gene Expression Profile of Glioblastoma Multiforme Invasive Phenotype Points to New Therapeutic Targets

    Authors: , , , , , , , , - Neoplasia 2005 cited by 323

  18. Dichotomy of astrocytoma migration and proliferation

    Authors: , , , , , - International Journal of Cancer 1996 cited by 415

  19. Migration of Human Glioma Cells on Myelin

    Authors: , , , , , - Neurosurgery 1996 cited by 196

  20. Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma

    Authors: , , , , , , , , , , , , , - Neuro-Oncology Practice 2019 cited by 74

  21. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma

    Authors: , , , , , , , , , , , , , , - Nature Communications 2019 cited by 74

  22. Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment

    Authors: , , - JNCI Journal of the National Cancer Institute 2007 cited by 376

  23. Evolving Feature Selection

    Authors: , , , , , , , , , , , , - IEEE Intelligent Systems, IEEE Intell. Syst. 2005 cited by 226

  24. Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration

    Authors: , , , , - Oncogene 2008 cited by 174